“…However, some technical disadvantages of the method prevent, for the moment, its brother use in clinical setups. We have already reported OCT as a promising tool for brain imaging (Osiac, Balseanu, Mogoanta, et al, 2014), but extensive and detailed investigations for clearer and unambiguous connection with the morphology and physiology of the observed processes, are still to be done (Osiac, Balseanu, Catalin, et al, 2014; Sato et al, 2019). As such we wanted to test its potential in a different neurological disorder, one that can have long‐lasting cellular changes in the brain (Donat, Scott, Gentleman, & Sastre, 2017; McColl et al, 2018; Witcher et al, 2018; Zhao et al, 2018) and a high cost of monitoring (van Dijck et al, 2019), in the hope that, with technological improvements, OCT could become a cheaper and faster alternative to MRI.…”